cas 4949-44-4|| where to buy Ethyl 3-oxopentanoate

Nom du produit:Ethyl 3-oxopentanoate

IUPAC Name:ethyl 3-oxopentanoate

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM253179-1000g	in stock	ȃƿŹ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 4949-44-4 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:4949-44-4; Formule moléculaire:C7H12O3; Point de fusion:-; Code SMILES:CCC(CC(OCC)=O)=O; Densité:

: Numéro de catalogue:CM253179; Poids moléculaire:144.17; Point d'ébullition:193°C at 760 mmHg; N° Mdl:MFCD00009317; Stockage:Keep in a tight container and store at ambient temperature,protect from light

: VX-548; Vertex announced positive results from its Phase 2 dose-ranging study of VX-548 in people with painful diabetic peripheral neuropathy (DPN). VX-548 is an investigational oral, selective NaV1.8 inhibitor that is highly selective for NaV1.8 relative to other NaV channels. NaV1.8 is a voltage-gated sodium channel that plays a critical role in pain signaling in the peripheral nervous system. NaV1.8 is a genetically validated target for the treatment of pain. Vertex's strategy is to develop new drug types by selectively inhibiting NaV1.8. Compared to opioid drugs, they may provide better analgesic effects while avoiding side effects such as addiction. VX-548 has been granted Breakthrough Therapy and Fast Track designations in the U.S. for moderate to severe acute pain.